Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Strides
FDA Approves OXYCODONE HYDROCHLORIDE — Strides Pharma Science Limited

Strides Pharma Science Limited announced the FDA approval of its oral Oxycodone Hydrochloride generic, a move anticipated to intensify competitive pri...

Dr.
FDA Approves ONDANSETRON — Dr. Reddy's Laboratories Limited

# FDA Approves Dr. Reddy's Laboratories' Generic Ondansetron Dr. Reddy's Laboratories Limited received FDA approval for its generic ondansetron hydro...

West-Ward
FDA Approves ONDANSETRON — West-Ward Pharmaceuticals Corp

West-Ward Pharmaceuticals Corp. secured FDA approval for its intramuscular formulation of ondansetron hydrochloride, a move that positions the company...

West-Ward
FDA Approves ONDANSETRON — West-Ward Pharmaceuticals Corp

West-Ward Pharmaceuticals Corp has received FDA approval for Ondansetron Hydrochloride Intramuscular Injection (ANDA 076780), strengthening the compan...

STRIDES
FDA Approves Unknown Drug — STRIDES PHARMA

Strides Pharma announced the FDA approval of Metolazone Tablets, expanding its portfolio of cardiac and kidney care generic therapies and reinforcing ...

Amneal
FDA Approves COLESTIPOL HYDROCHLORIDE — Amneal Pharmaceuticals of New York LLC

# FDA Approves Amneal Pharmaceuticals' Generic Colestipol Hydrochloride Amneal Pharmaceuticals of New York LLC received FDA approval for its generic ...

LANNETT
FDA Approves Unknown Drug — LANNETT CO INC

# FDA Approves ANDA for Lannett Co Inc Lannett Co Inc received FDA approval for ANDA077960 on October 13, 2006, expanding its generic drug portfolio ...

Amneal
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Amneal Pharmaceuticals of New York LLC

Amneal Pharmaceuticals of New York LLC announced the approval of its abbreviated new drug application (ANDA) for hydrocodone bitartrate and acetaminop...

Amneal
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals LLC has been granted approval for the ANDA040746 filing, securing the generic market for FDA-approved, oral-conditioned hydroco...

GRAVITI
FDA Approves Unknown Drug — GRAVITI PHARMS

Gravi Pharma announced that its generic drug has received FDA approval, a development expected to facilitate market entry and potentially generate rev...

STRIDES
FDA Approves Unknown Drug — STRIDES PHARMA INTL

Strides Pharma Intl announced the approval of a generic drug application in January 2006. This early-stage development marked a significant step for t...

SOLA
FDA Approves CABERGOLINE — SOLA Pharmaceuticals, LLC

# FDA Approves SOLA Pharmaceuticals' Generic Cabergoline The FDA has approved SOLA Pharmaceuticals' abbreviated new drug application for generic cabe...

SUN
FDA Approves Unknown Drug — SUN PHARM INDUSTRIES

SUN PHARM INDUSTRIES received final FDA approval on December 21 for ANDA077124, signaling a potential generic opportunity in the previously undetermin...

Torrent
FDA Approves CARBAMAZEPINE — Torrent Pharmaceuticals Limited

# FDA Approves Torrent Pharmaceuticals' Generic Carbamazepine Torrent Pharmaceuticals Limited has received FDA approval for its generic carbamazepine...

EPIC
FDA Approves Unknown Drug — EPIC PHARMA LLC

Epic Pharma LLC announced the approval of its Abbreviated New Drug Application (ANDA) for generic drug **[Substance]** on October 27, 2005. This clear...

BARR
FDA Approves Unknown Drug — BARR

# FDA Approves Generic Drug Application for Barr Pharmaceuticals Barr Pharmaceuticals received FDA approval for ANDA077083 on September 13, 2005, exp...

WATSON
FDA Approves Unknown Drug — WATSON LABS

# FDA Approves Watson Labs Generic Drug Application Watson Labs received FDA approval for abbreviated new drug application ANDA076417 on April 18, 20...

Mylan
FDA Approves FENTANYL — Mylan Pharmaceuticals Inc.

Mylan Pharmaceuticals Inc. received FDA approval for its Abbreviated New Drug Application for transdermal fentanyl, authorizing the launch of a generi...

URONOVA
FDA Approves VABRINTY — URONOVA PHARMACEUTICALS, INC.

Uronova Pharmaceuticals’ approval of its subcutaneous leuprolide acetate injection introduces new competition in the hormone therapy market, providing...

SANDOZ
FDA Approves Unknown Drug — SANDOZ

Sandoz received FDA approval on December 14, 2004, for its Abbreviated New Drug Application (ANDA076223), signaling a significant move downstream in t...